FrontRow: Carol Ann Duffy 30Sep11Mark Lawson
An economic evaluation alongside the trial will be conducted to determine whether the ROWTATE VR intervention plus usual care is cost effective compared to usual care alone at 12 months post-randomisation. As recommended by NICE guidance [67] (2022), the primary health economic analysis will take...